Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Clinical Teacher|December 20, 2020
A Springboard for physicians returning to practiceClaire Mullender, Emily Gowland, Charlotte Ford, et al.
British Journal of Pharmacology|March 29, 2022
Niclosamide-A promising treatment for COVID-19Shivani Singh, Anne Weiss, James Goodman, et al.
BMJ Open|June 3, 2025
Definitions of early COPD and markers and tools for predicting progression: a systematic review protocolAlastair Watson, Gbenga Adesoye, Kane Alexander, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 11, 2026
Definitions of early COPD and predictors for disease progression: a systematic reviewAlastair Watson, Ross Davidson, Fu Chuen Kon, et al.
Pulmonary Pharmacology & Therapeutics|May 2, 2021
Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19Marie Fisk, Magnus Althage, Sven Moosmang, et al.
BMJ Open Respiratory Research|June 14, 2023
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICAHolly Pavey, Michael I Polkey, Charlotte E Bolton, et al.
EJNMMI Research|May 27, 2017
Quantitative analysis of dynamic <sup>18</sup>F-FDG PET/CT for measurement of lung inflammationChristopher Coello, Marie Fisk, Divya Mohan, et al.
Trials|July 10, 2020
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trialSpoorthy Kulkarni, Marie Fisk, Michalis Kostapanos, et al.
Respiratory Research|May 26, 2018
Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary diseaseMarie Fisk, Joseph Cheriyan, Divya Mohan, et al.
BMC Infectious Diseases|September 8, 2016
Determinants of treatment-related paradoxical reactions during anti-tuberculosis therapy: a case control studyColin Stewart Brown, Colette Joanne Smith, Ronan Angus MacCormick Breen, et al.
Pageof 4